| | | Hydroxy-PEG8-acetic acid CAS:780006-30-6 Formula: C18H36O11 >97% BP-501658 Hydroxy-PEG8-CH2CO2H; HO-PEG8-CH2-COOH; 26-Hydroxy-3,6,9,12,15,18,21,24-octaoxahexacosan-1-oic acid; 3,6,9,12,15,18,21,24-Octaoxahexacosan-1-oic acid, 26-hydroxy- HYDROXY-PEG8-PROPIONIC ACID CAS:937188-60-8 Formula: C19H38O11 >98% BP-500846 OH-PEG8-COOH; HO-PEG8-Propionic acid; HO-PEG8-CH2CH2COOH; Hydroxy-PEG8-acid; 1-Hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oic acid; +¦-hydroxy--ë-propionic acid octaethylene glycol; 3-[(23-Hydroxy-3,6,9,12,15,18,21-heptaoxatricos-1-yl) HYDROXY-PEG8-T-BUTYL ESTER CAS:1334177-84-2 Formula: C23H46O11 GëÑ95% BP-500085 HO-PEG8-CH2CH2COOtBu; Hydroxy-PEG8-(CH2)2-Boc; OH-PEG8-TBA; OH-PEG8-CH2CH2COOtBu; HO-PEG8-t-butyl ester; tert-Butyl 1-Hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate; t-Butyl 1-hydroxy-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate; HYDROXY-PEG9-T-BUTYL ESTER CAS:2055042-66-3 Formula: C25H50O12 GëÑ95% BP-501096 HO-PEG9-CH2CH2COOtBu; Hydroxy-PEG9-(CH2)2-Boc; OH-PEG9-TBA; OH-PEG9-CH2CH2COOtBu; HO-PEG9-t-butyl ester; 2-Methyl-2-propanyl 1-hydroxy-3,6,9,12,15,18,21,24,27-nonaoxatriacontan-30-oate; 4,7,10,13,16,19,22,25,28-Nonaoxatriacontanoic acid, 30 HYDROXYSAFFLOR YELLOW A CAS:78281-02-4 Formula: C27H32O16 >98% NP0993 2,5-Cyclohexadien-1-one, 2,4-di-+¦-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-; 2,4-Di-+¦-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-2,5-cyclohexadien-1-one; 2,5- HYDROXYTUBEROSONE CAS:95456-43-2 Formula: C20H18O6 98.0% NP4719 Hydroxytuberosone; 95456-43-2; 1,14-dihydroxy-7,7-dimethyl-8,12,20-trioxapentacyclo[11.8.0.02,11.04,9.014,19]henicosa-2(11),3,5,9,15,18-hexaen-17-one HYGROLIDIN CAS:83329-73-1 Formula: C38H58O11 GëÑ97.0% 83329-73-1 (E)-4-[(2R,4R,5S,6R)-6-ethyl-2-hydroxy-2-[(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9S,10S,11R,12Z,14Z)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-5-methyloxan-4-yl]oxy-4-oxobut-2- HYMEGLUSIN CAS:29066-42-0 Formula: C29H28ClFN6O3 GëÑ95% BBF-03480 Hymeglusin;Antibiotic 1233A;29066-42-0;L-659,699;(2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid;2,4-Undecadienoic acid, 11-[(2R,3R)-3-(hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-, (2E HYNAPENE A CAS:155111-89-0 Formula: C18H28O5 BBF-01485 5-(1,3,4-Trihydroxy-2,6,8-trimethyldecalin)-2,4-pentadienoic acid; 2,4-Pentadienoic acid, 5-(decahydro-1,3,4-trihydroxy-2,6,8-trimethyl-1-naphthalenyl)- HYNAPENE B CAS:155111-88-9 Formula: C18H24O3 99% BBF-01486 5-(1-Ene-3-oxo-2,6,8-trimethyldecalin)-2,4-pentadienoic acid; 2,4-Pentadienoic acid, 5-(3,4,4a,5,6,7,8,8a-octahydro-2,6,8-trimethyl-3-oxo-1-naphthalenyl)- HYNAPENE C CAS:155111-90-3 Formula: C18H24O3 BBF-01487 5-(3-Ene-1-oxo-2,6,8-trimethyldecalin-2-yl)-2,4-pentadienoic acid; 2,4-Pentadienoic acid, 5-(1,2,4a,5,6,7,8,8a-octahydro-2,6,8-trimethyl-1-oxo-2-naphthalenyl)- HYOSCINE BUTYLBROMIDE IMPURITY G CAS:92714-23-3 Formula: C21H28BrNO3 >95% B2694-479472 (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Butyl-9-methyl-7-[(1-oxo-2-phenyl-2-propenyl)oxy]-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide; 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-9-methyl-7-[(1-oxo-2-phenyl-2-propenyl)oxy]-, bromide, (1+¦,2+¦,4+¦,5+¦,7+¦) Hyoscyamine hemisulfate hydrate CAS:6835-16-1 Formula: 2(C17H23NO3).H2O4S.2(H2O) GëÑ95% B2703-152649 Benzeneacetic acid, +¦-(hydroxymethyl)-, (+¦S)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, sulfate, hydrate (2:1:2); 1+¦H-Tropan-3+¦-ol, (-)-tropate (ester), sulfate (2:1), dihydrate; Benzeneacetic acid, +¦-(hydroxymethyl)-, 8-methyl- HYPACONITINE CAS:6900-87-4 Formula: C33H45NO10 >98% NP0562 (1-alpha,6-alpha,14-alpha,15-alpha,16-beta)-acetatebenzoat; 15-tetraol,16,16-trimethoxy-4-(methoxymethyl)-20-methyl-18-aconitane-14; Aconitane-8,13,14,15-tetrol,1,6,16-trimethoxy-4-(methoxymethyl)-20-methyl-,8-acetate 14-benzoate, (1+¦,6+¦,14 HYPERFORIN CAS:11079-53-1 Formula: C35H52O4 >95% BBF-01874 hiperforina; hyperforine; (1R,5S,6R,7S)-4-hydroxy-6-methyl-1,3,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)-5-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione; Bicyclo[3.3.1]non-3-ene-2,9-dione, 4-hydroxy-6-methyl-1,3,7-tris HYPERICIN-D10 Formula: C30H6O8D10 > 95% 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione-d10; 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione P-conformer-d10; Cyclo-Werol-d10; Cyclosan-d10; Hyperflav-d10; Hy HYPOCONSTICTIC ACID CAS:78916-52-6 Formula: C19H16O9 BBF-05581 7H-Isobenzofuro[4,5-b][1,4]benzodioxepin-3,7(1H)-dione, 1,4-dihydroxy-5-(hydroxymethyl)-10-methoxy-8,11-dimethyl-; 1,4-Dihydroxy-5-hydroxymethyl-10-methoxy-8,11-dimethyl-1H-benzo[e]furo[3',4':3,4]benzo[b][1,4]dioxepine-3,7-dione HYPOCRELLIN B CAS:123940-54-5 Formula: C30H26O10 98% 123940-54-5 hypocrellin b; Hypocrellin C; 123940-54-5; 149457-83-0; 12-acetyl-9,17-dihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaene-7,19-dione HYPOGLAUNINE D CAS:220751-00-8 Formula: C41H47NO19 GëÑ95% 220751-00-8 2-Furancarboxylic acid, [(9S,10S,11S,12R,13S,14R,15R,16R,21R,22R,23R)-13,14,21,22,23-pentakis(acetyloxy)-5,6,7,9,10,14,15,16,17,19-decahydro-10-hydroxy-5,6,10,16-tetramethyl-7,19-dioxo-11,16-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacyc HYPOPHYSCIOSPORIN CAS:64662-23-3 Formula: C19H17ClO7 GëÑ95% BBF-05510 11H-Dibenzo[b,e][1,4]dioxepin-7-carboxylic acid, 2-chloro-3,8-dihydroxy-1,4,6,9-tetramethyl-11-oxo-, methyl ester; 2-chloro-3,8-dihydroxy-1,4,6,9-tetramethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester HYPOPROTOCETRARIC ACID CAS:4665-02-5 Formula: C18H16O7 BBF-05396 Coquimboic acid; 3,9-dihydroxy-1,4,7,10-tetramethyl-6-oxobenzo[b][1,4]benzodioxepine-2-carboxylic acid; Hypoprotocetrarsaeure; 3,8-Dihydroxy-1,4,6,9-tetramethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure; 1,4,6,9-Tetramethyl-3,8-di HYPOSTICTIC ACID CAS:68729-11-3 Formula: C19H16O8 GëÑ98% BBF-05534 Hypostatic acid; 1,4-Dihydroxy-10-methoxy-5,8,11-trimethyl-1H-benzo[e]furo[3',4':3,4]benzo[b][1,4]dioxepine-3,7-dione; 7H-Isobenzofuro[4,5-b][1,4]benzodioxepin-3,7(1H)-dione, 1,4-dihydroxy-10-methoxy-5,8,11-trimethyl- Hypoxanthine-[13C,15N2] CAS:244769-71-9 Formula: C4[13C]H4N2[15N]2O GëÑ98% 244769-71-9 Hypoxanthine-15N2,13C; 6-Oxopurine-13C,15N2; 1,9-Dihydro-6H-purin-6-one-13C,15N2; 3H-Purin-6-ol-13C,15N2; 6-Hydroxy-1H-purine-13C,15N2; 6-Hydroxypurine-13C,15N2; Hypoxanthine enol-13C,15N2; Sarcine-13C,15N2; Sarkin-13C,15N2 HYPOXANTHINE-[13C2,15N] CAS:1246820-04-1 Formula: C5H4N4O 95% by HPLC; 98% atom 13C, 98% atom 15N BLP-009722 1,9-Dihydro-6H-purin-6-one-13C2,15N; 3H-Purin-6-ol-13C2,15N; 6-Hydroxy-1H-purine-13C2,15N; 6-Hydroxypurine-13C2,15N; 6-Oxopurine-13C2,15N; Hypoxanthine Enol-13C2,15N; NSC 129419-13C2,15N HYPOXANTHINE-[13C3,15N2] Formula: C2[13C]3H4N2[15N]2O BLP-005903 1,9-Dihydro-6H-purin-6-one-13C2,15N; 3H-Purin-6-ol-13C2,15N; 6-Hydroxy-1H-purine-13C2,15N; 6-Hydroxypurine-13C2,15N; 6-Oxopurine-13C2,15N; Hypoxanthine enol-13C2,15N; Purin-6-ol-13C2,15N; Sarcine-13C2,15N; Sarkine-13C2,15N HYPTADIENIC ACID CAS:128397-09-1 Formula: C30H46O4 >98% NP6730 Hyptadienic acid; 128397-09-1; (3aS,5aR,5bS,7aS,10R,11R,11aS,13aS,13bS)-11-hydroxy-1-(hydroxymethyl)-3,3,5a,5b,10,11,13b-heptamethyl-4,5,6,7,8,9,10,11a,13,13a-decahydro-3aH-cyclopenta[a]chrysene-7a-carboxylic acidHypadienic acidhyptasienic I-CHOLESTANE CAS:465-56-5 Formula: C27H46 BBF-05394 i-Cholestane; 3,5-Cyclocholestane; (3aR,3bS,5aR,6R,8aS,8bS)-3a,5a-dimethyl-6-((R)-6-methylheptan-2-yl)hexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-f]naphthalene; (3+¦,5+¦)-3,5-Cyclocholestane i-Urobilinogen CAS:14684-37-8 Formula: C33H44N4O6 GëÑ95% 14684-37-8 21H-Biline-8,12-dipropanoic acid, 2,17-diethyl-1,4,5,10,15,16,19,22,23,24-decahydro-3,7,13,18-tetramethyl-1,19-dioxo-; Biline-8,12-dipropionic acid, 2,17-diethyl-1,4,5,10,15,16,19,22,23,24-decahydro-3,7,13,18-tetramethyl-1,19-dioxo-; 3-(2-( Iandonone CAS:366487-98-1 Formula: C20H26O9 GëÑ95% 366487-98-1 Picras-3-ene-2,16-dione, 11,20-epoxy-1,11,12,14,15-pentahydroxy-, (1+¦,11+¦,12+¦,15+¦)-; (1R,2R,3S,3aR,3a1R,4S,6aR,7aS,11S,11aS,11bR)-1,2,3a,4,11-pentahydroxy-3,8,11a-trimethyl-1,2,3,3a,4,7,7a,11,11a,11b-decahydro-5H-1,3a1-(epoxymethano)dibenzo Iandonoside A CAS:366497-87-2 Formula: C26H38O13 GëÑ95% 366497-87-2 Picras-3-en-16-one, 11,20-epoxy-2-(+¦-D-glucopyranosyloxy)-1,11,12,15-tetrahydroxy-, (1+¦,2+¦,11+¦,12+¦,15+¦)-; (1R,2R,3R,3aS,3a1S,4S,6aR,7aS,10S,11S,11aS,11bR)-1,2,4,11-tetrahydroxy-3,8,11a-trimethyl-10-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hyd Iandonoside B CAS:366487-97-0 Formula: C26H38O14 GëÑ95% 366487-97-0 Picras-3-en-16-one, 2-(+¦-D-glucopyranosyloxy)-11,20-epoxy-1,11,12,14,15-pentahydroxy-, (1+¦,2+¦,11+¦,12+¦,15+¦)-; (1R,2R,3S,3aR,3a1R,4S,6aR,7aS,10S,11S,11aS,11bR)-1,2,3a,4,11-pentahydroxy-3,8,11a-trimethyl-10-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy- ibrexafungerp CAS:1207753-03-4 Formula: C44H67N5O4 98% BBF-05813 Brexafemme; SCY-078; MK3118; 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyri Ibrexafungerp Citrate CAS:1965291-08-0 Formula: C50H75N5O11 98% BBF-05812 Brexafemme Citrate; SCY-078 Citrate; MK-3118 Citrate; 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a- IBUPROFEN ACYL-BETA-D-GLUCURONIDE CAS:115075-59-7 Formula: C19H26O8 > 95% 115075-59-7 Ibuprofen glucuronide; (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[2-(4-Isobutylphenyl)Propanoyloxy]Tetrahydropyran-2-Carboxylic Acid; (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[2-(4-Isobutylphenyl)-1-Oxopropoxy]-2-Tetrahydropyrancarboxylic Acid; Ibupro ICTEROGENIN CAS:561-47-7 Formula: C35H52O6 98.0% NP7132 Icterogenin; (4R,4aS,6aR,6aS,6bR,9S,12aR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-4-[(E)-2-methylbut-2-enoyl]oxy-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid; 561-47-7; Olean-12-en-28-oic acid, 22 IDARUBICIN DIOXOLANE HYDROCHLORIDE Formula: C28H31NO10.HCl (7S,9S)-7-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-9-(2-methyl-1,3-dioxolan-2-yl)-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride IDARUBICIN HYDROCHLORIDE CAS:57852-57-0 Formula: C26H28ClNO9 >98% B0084-094874 (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Hydrochloride; 4-DMD HCl; 4-Demethoxydaunorubicin Hydrochloride; Idamycin; NSC 256439; Zavedos; (1S,3S)-3-Ac Idarubicin Impurity 4 CAS:85440-44-4 Formula: C28H26F3NO9 85440-44-4 N-[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,12-dihydroxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2,2,2-trifluoroacetamide; 5,12-Naphthacenedione, 9-acetyl-7,8,9,10-tetrahydro-6,9-dihydroxy-7-[[2,3,6-trideoxy-3- IDARUBICIN ISOMER CAS:58957-93-0 Formula: C26H27NO9 GëÑ95% 58957-93-0 (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranoside; (7S-cis)-9-Acetyl-7-((3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy Idarubicin Isomer hydrochloride CAS:60660-72-2 Formula: C26H27NO9.HCl 60660-72-2 (7S,9S)-9-Acetyl-7-(((2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; Idarubicin Impurity 6; (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4 IDARUBICINOL CAS:86189-66-4 Formula: C26H29NO9 > 95% 86189-66-4 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-, (7S,9S)-; (7S,9S)-7-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,1 IDARUBICINOL-D4 Formula: C26H25NO9D4 > 95% Idarubicinol-d4 (Mixture of Diastereomers); (7S,9S)-7-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-naphthacenedione-d4; [7S-[7+¦,9+¦,9(R*)]]-7-[(3-Amino-2,3,6-trideox IDARUBICINONE CAS:60660-75-5 Formula: C20H16O7 GëÑ95% B0709-003996 4-demethoxy daunomycinone; (7S,9S)-9-acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione; 4-Demethoxydaunomycinone; Idarubicin aglycone; (+)-4-Demethoxydaunomycinone; 5,12-Naphthacenedione, 9-acetyl-7,8,9,10-tetrahydro-6,7, IDAZOXAN HYDROCHLORIDE CAS:79944-56-2 Formula: C11H13ClN2O2 GëÑ98% B2693-033520 1H-Imidazole, 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-, hydrochloride (1:1); 1H-Imidazole, 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-, monohydrochloride; (-¦)-Idazoxan monohydrochloride; 2-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl IDEBENONE-[13C,D3] CAS:1189907-75-2 Formula: C18[13C]H27D3O5 98% by CP BLP-005872 2-(10-Hydroxydecyl)-6-methoxy-5-(methoxy-13C,d3)-3-methyl-2,5-cyclohexadiene-1,4-dione; 2,3-Dimethoxy-6-(10-hydroxydecyl)-5-methyl-1,4-benzoquinone-13C,d3; Avan-13C,d3; Daruma-13C,d3; Idebenone-13C,d3; Mnesis-13C,d3 IFOSFAMIDE CAS:3778-73-2 Formula: C7H15Cl2N2O2P >98% B2693-114093 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide; 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide; (2-Chloro-ethyl)-[3-(2-chloro-ethyl)-2-oxo-2++*5*-[1,3,2]oxazaphosphinan IHVR-17028 CAS:1428247-78-2 Formula: C23H44N2O5 GëÑ98% (HPLC) 1428247-78-2 Propanamide, N-cyclohexyl-2,2-dimethyl-N-[6-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)-1-piperidinyl]hexyl]-; N-Cyclohexyl-2,2-dimethyl-N-{6-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)-1-piperidinyl]hexyl}propanamide IHVR-19029 CAS:1447464-73-4 Formula: C23H45N3O5 1447464-73-4 IHVR-19029;1447464-73-4;3-tert-butyl-1-cyclohexyl-1-[6-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexyl]urea;3-tert-butyl-1-cyclohexyl-1-{6-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexyl}urea;CHEM IL-17A ANTAGONIST 3 CAS:2230780-65-9 Formula: C33H33ClN6O4 GëÑ95% 2230780-65-9 (4S,20R)-7-Chloro-N-methyl-4-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-3,18-dioxo-2,19-diazatetracyclo[20.2.2.16,10.111,15]octacosa-1(24),6(28),7,9,11(27),12,14,22,25-nonaene-20-carboxamide; 2,19-Diazatetracyclo[20.2.2.16,10.111,15]octaco |